Literature DB >> 12483528

Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells.

Takehiko Segawa1, Martin E Nau, Linda L Xu, Rao N Chilukuri, Mazen Makarem, Wei Zhang, Gyorgy Petrovics, Isabell A Sesterhenn, David G McLeod, Judd W Moul, Maryanne Vahey, Shiv Srivastava.   

Abstract

Evaluations of androgen regulated gene (ARG) repertoire provide new insights into the androgen receptor (AR) mediated signaling at the transcriptional level. Definition of ARGs having critical functions in the biology of normal and malignant prostate should aid in identifying new bio-markers and therapeutic targets for prostate cancer (CaP). Using Affymetrix HuGene FL oligonucleotide arrays, temporal expression profiles of ARGs in widely used hormone responsive LNCaP cells, were analysed by hierarchical clustering methods and functional classification. ARGs in response to different androgen concentrations showed temporal co-regulation of genes involved in specific biochemical pathways. This study focuses on our new observations of the coordinated androgen induction of genes (NDRG1, PDIR, HERPUD1, ORP150) involved in the endoplasmic reticulum (ER) stress response pathway. Expression analysis of the two selected ER stress responsive genes, NDRG1 and HERPUD1 in primary CaPs revealed a significantly reduced tumor associated expression. Intriguing linkage of the androgen signaling to ER stress responsive genes, a protective response to protein unfolding or protein damage resulting from cellular stress signals, suggests that androgens may induce such stress signals in CaP cells. Decreased CaP associated expression of two ER stress responsive genes also suggests that possible abrogation of this pathway in prostate tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483528     DOI: 10.1038/sj.onc.1205992

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Determination of tag density required for digital transcriptome analysis: application to an androgen-sensitive prostate cancer model.

Authors:  Hairi Li; Michael T Lovci; Young-Soo Kwon; Michael G Rosenfeld; Xiang-Dong Fu; Gene W Yeo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

2.  Androgen modulation of coregulator expression in prostate cancer cells.

Authors:  Hannelore V Heemers; Kevin M Regan; Lucy J Schmidt; S Keith Anderson; Karla V Ballman; Donald J Tindall
Journal:  Mol Endocrinol       Date:  2009-01-22

3.  Identification of a clinically relevant androgen-dependent gene signature in prostate cancer.

Authors:  Hannelore V Heemers; Lucy J Schmidt; Zhifu Sun; Kevin M Regan; S Keith Anderson; Kelly Duncan; Dan Wang; Song Liu; Karla V Ballman; Donald J Tindall
Journal:  Cancer Res       Date:  2011-02-15       Impact factor: 12.701

4.  Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

Authors:  Harold D Love; S Erin Booton; Braden E Boone; Joan P Breyer; Tatsuki Koyama; Monica P Revelo; Scott B Shappell; Jeffrey R Smith; Simon W Hayward
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

5.  Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.

Authors:  Jan-Hendrik Bebermeier; James D Brooks; Samuel E DePrimo; Ralf Werner; Uta Deppe; Janos Demeter; Olaf Hiort; Paul-Martin Holterhus
Journal:  J Mol Med (Berl)       Date:  2006-08-24       Impact factor: 4.599

6.  Association between metformin medication, genetic variation and prostate cancer risk.

Authors:  Min Joon Lee; Viranda H Jayalath; Wei Xu; Lin Lu; Stephen J Freedland; Neil E Fleshner; Girish S Kulkarni; Antonio Finelli; Theodorus H van der Kwast; Robert J Hamilton
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-05-18       Impact factor: 5.554

7.  Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.

Authors:  Akash K Kaushik; Shaiju K Vareed; Sumanta Basu; Vasanta Putluri; Nagireddy Putluri; Katrin Panzitt; Christine A Brennan; Arul M Chinnaiyan; Ismael A Vergara; Nicholas Erho; Nancy L Weigel; Nicholas Mitsiades; Ali Shojaie; Ganesh Palapattu; George Michailidis; Arun Sreekumar
Journal:  J Proteome Res       Date:  2013-12-31       Impact factor: 4.466

8.  Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

Authors:  Amjad P Khan; Laila M Poisson; Vadiraja B Bhat; Damian Fermin; Rong Zhao; Shanker Kalyana-Sundaram; George Michailidis; Alexey I Nesvizhskii; Gilbert S Omenn; Arul M Chinnaiyan; Arun Sreekumar
Journal:  Mol Cell Proteomics       Date:  2009-11-09       Impact factor: 5.911

9.  Overexpression of ETS-1 is associated with malignant biological features of prostate cancer.

Authors:  Bo Li; Yosuke Shimizu; Takashi Kobayashi; Naoki Terada; Koji Yoshimura; Tomomi Kamba; Yoshiki Mikami; Takahiro Inoue; Hiroyuki Nishiyama; Osamu Ogawa
Journal:  Asian J Androl       Date:  2012-10-15       Impact factor: 3.285

10.  LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.

Authors:  Tammy L Romanuik; Gang Wang; Olena Morozova; Allen Delaney; Marco A Marra; Marianne D Sadar
Journal:  BMC Med Genomics       Date:  2010-09-24       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.